These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19362971)

  • 21. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
    Jalali S; Ansell SM
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
    Sajid R; Siddiqui SH; Shaikh U; Adil S
    Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
    Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
    Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
    J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
    Moreau AS; Sebti Y; Duhamel A; Roccaro AM; Coiteux V; Gastinne T; Le Friec G; Burwick N; Amiot L; Ho AW; Poulain S; Hennache B; Hunter ZR; Dessaint JP; Ghobrial IM; Treon SP; Facon T; Zorn E; Leleu X
    Eur J Haematol; 2008 Jun; 80(6):503-9. PubMed ID: 18331603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    McMaster ML; Caporaso N
    Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waldenstrom's macroglobulinemia presenting with spinal cord compression: a case report.
    Al-Halabi H; Roberge D
    Am J Hematol; 2006 Dec; 81(12):955-8. PubMed ID: 16888782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypercalcemia complicating Waldenström's disease: a manifestation of Richter's syndrome].
    Casassus P; Vannetzel JM; Tricot G; D'Agay MF; Lortholary P; Desrues J; Pariente P
    Ann Med Interne (Paris); 1983; 134(2):130-3. PubMed ID: 6410954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia.
    Drexler HG; MacLeod RA
    Leuk Res; 2008 Nov; 32(11):1669-73. PubMed ID: 18533260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
    Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
    Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bone marrow niche in Waldenström's macroglobulinemia.
    Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa G; Roccaro A
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):118-20. PubMed ID: 21454209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow angiogenesis in multiple myeloma.
    Vacca A; Ribatti D
    Leukemia; 2006 Feb; 20(2):193-9. PubMed ID: 16357836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.